News

The world of MS information changes rapidly. Breakthroughs in understanding the mechanisms of MS, its cause, and its treatment come at a rapid pace. And there's so much to know just about managing the disease in your daily life! 

To keep you informed and up-to-date, MS Focus offers informative periodicals and round-the-clock multimedia broadcasting. Whether print or digital, these materials are designed to be easy to understand for MS patients, their families, and care providers. Subscriptions are free of charge.

Scientists discover how multiple sclerosis kills neurons

April 09, 2026

Inflammation caused by the disease damages DNA in neurons that are essential to higher thinking.
Learn more

Findings suggest mono linked to increased risk of MS

April 07, 2026

People with a history of infectious mononucleosis were more likely to develop MS than people without it.
Learn more

Gut may prime T cells responsible for MS inflammation

April 03, 2026

Researchers identify role of gut-derived cells in antigen presentation, a key initiator of autoimmune neuroinflammation.
Learn more

MS doubles in prevalence in England while survival rates improve

March 25, 2026

Researchers note smoking and obesity contribute to poor outcomes.
Learn more

Study: High-altitude survival gene may help reverse nerve damage

March 19, 2026

Naturally occurring molecule could be key to myelin sheath repair.
Learn more

Shared genetic roots of MS across diverse ancestries, study finds

March 12, 2026

Findings highlight how ancestry-specific genetic variants and effects can be missed when research lacks diversity.
Learn more

Cognitive testing tool proves useful in screening employment status in MS

March 11, 2026

Unemployed people with MS were more likely to show cognitive impairment across multiple domains, with executive function and attention most frequently impaired.
Learn more

Decrease in activity levels may be linked to disease progression

March 10, 2026

In MS, wearable sensors may help identify people at risk of worsening disability.
Learn more

Study suggests fenebrutinib’s potential as BTK Inhibitor

March 03, 2026

Phase III results show benefits for treating both relapsing and primary progressive MS.
Learn more

Scientists discover how multiple sclerosis kills neurons

April 09, 2026

Inflammation caused by the disease damages DNA in neurons that are essential to higher thinking.
Learn more

Findings suggest mono linked to increased risk of MS

April 07, 2026

People with a history of infectious mononucleosis were more likely to develop MS than people without it.
Learn more

Gut may prime T cells responsible for MS inflammation

April 03, 2026

Researchers identify role of gut-derived cells in antigen presentation, a key initiator of autoimmune neuroinflammation.
Learn more

MS doubles in prevalence in England while survival rates improve

March 25, 2026

Researchers note smoking and obesity contribute to poor outcomes.
Learn more

Study: High-altitude survival gene may help reverse nerve damage

March 19, 2026

Naturally occurring molecule could be key to myelin sheath repair.
Learn more

Shared genetic roots of MS across diverse ancestries, study finds

March 12, 2026

Findings highlight how ancestry-specific genetic variants and effects can be missed when research lacks diversity.
Learn more

Cognitive testing tool proves useful in screening employment status in MS

March 11, 2026

Unemployed people with MS were more likely to show cognitive impairment across multiple domains, with executive function and attention most frequently impaired.
Learn more

Decrease in activity levels may be linked to disease progression

March 10, 2026

In MS, wearable sensors may help identify people at risk of worsening disability.
Learn more

Study suggests fenebrutinib’s potential as BTK Inhibitor

March 03, 2026

Phase III results show benefits for treating both relapsing and primary progressive MS.
Learn more

Spending bill to curtail practices of pharmacy middlemen

February 19, 2026

Change would require PBMs to pass through 100 percent of rebates to health plans.
Learn more

Fenebrutinib reduces disability progression in primary progressive MS

February 10, 2026

Phase III results show investigational fenebrutinib met primary endpoint of no-inferiority compared to Ocrevus in reducing disability progression in PPMS.
Learn more

Researchers are closer to finding Epstein-Barr virus, MS link

February 09, 2026

“Killer” T immune cells may play key role in disease.
Learn more

Study finds backward walking may improve gait in MS patients

February 06, 2026

Findings offer potential new treatment to promote neuroplasticity.
Learn more

Study suggests mindset is central to walking experience

January 26, 2026

Findings uncover the effects of stigma and emotion of walking with MS.
Learn more

Study sheds new light on link between Epstein-Barr and MS

January 14, 2026

The new findings suggest that, rather than acting only indirectly, B cells may also play a direct role at the earliest stages of lesion formation.
Learn more

Findings suggest oral bacterium, MS disability severity link

January 07, 2026

Researchers think there is a need to evaluate whether dental interventions may modify disease activity or disability progression in MS.
Learn more

Exposure to PFAS and PCBs may be linked to higher odds of MS

December 22, 2025

Study highlights how environmental contaminants can interact with hereditary factors.
Learn more

Study suggests certain gut bacteria may drive MS

December 16, 2025

“Molecular mimicry” may contribute to disease progression.
Learn more


Show More News